account1.51 billion rupees for the firm. The year ago quarter benefited from sales of generic version of GlaxoSmithKline's herpes treatment Valtrex. Net sales fell 13.6 percent to 21.4 billion rupees. The company's shares closed up 2 percent in Tuesday trade,...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
Reactions to RPT-UPDATE 1-India Ranbaxy Q1 net down 68 pct; drop less than f'cast
Join Business Exchange
to access the most relevant content for you, filtered by like-minded business professionals. Learn more
account